Efficacy of Static Progressive Stretch Versus Traditional Stretch in Adhesive Capsulitis
NCT ID: NCT05988255
Last Updated: 2025-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2023-09-01
2024-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Mobilization and Capsular Stretching in Adhesive Capsulitis
NCT07323225
Application of an Exercise Program Versus Exercise Plus Manual Therapy in the Treatment of Adhesive Capsulitis.
NCT06497348
Manual Treatment and Proprioceptive Neuromusculer Fasilitation Techniques for Patients With Adhesive Capsulitis
NCT03705975
Education-based Physical Therapy Approach for Adhesive Capsulitis
NCT03245476
Formal Physical Therapy (PT) vs. Home PT for Adhesive Capsulitis
NCT03049787
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The sample size is calculated using G\*power software (version 3.1.9.7, Franz Faul, Universitat Kiel, Germany) and it suggests that 42 participants (14 per group) will be needed using the MANOVA test. Cohen's d is set to be 0.25 with 80% power (alpha = 0.05) to detect an effect size.
Patients are randomly assigned to either of three groups (A, B, or C) using a computer-generated list. They are allocated by an outside party who isn't involved in the treatment using sequentially numbered sealed envelopes.
Inclusion criteria: (1) Patients of both genders with unilateral primary adhesive capsulitis (2) Patients aged between 40-65. (3) Pain duration of three months or more. (4) Range of motion loss of greater than 25% in at least 2 planes and passive external rotation loss that is greater than 50% of the uninvolved shoulder or less than 30° of external rotation.
Exclusion criteria: (1) Previous surgery or manipulation under anesthesia. (2) Other conditions affecting the shoulder as (rheumatoid arthritis, osteoarthritis, rotator cuff disease, or malignancies). (3) Neurological deficits affecting shoulder function.
Demographic data will be collected for all subjects regarding age, gender, dominance, and painful side. After patient selection according to the inclusion and exclusion criteria, we will measure shoulder range of motion (ROM) using a Baseline Digital Absolute Axis Goniometer, and shoulder function using the SPADI scale.
Range of motion will be assessed at baseline (before the start of treatment), at the end of each week, and at the end of 12 weeks.
Shoulder function will be assessed using SPADI at baseline (before the start of treatment) and at the end of treatment.
The mean time needed to reach ROM at 3 months will be assessed in each group and compared between groups.
Treatment procedures:
All patients in the three groups will be educated about the natural history of the disease and instructed to stay active at home through encouraging activity modification without pain. Each patient in the treatment groups will receive two treatment sessions per week for a series of 12 weeks.
1. Static progressive stretching using JAS shoulder device (Group A): The static progressive stretch device applies stretch toward external and internal rotation from different degrees of scapular plane abduction. After adjustment of the device, it will be worn for 45 minutes (30 minutes stretching toward external rotation and 15 minutes toward internal rotation). The stretch position will be held for a series of 5 minutes and rest in between according to patient tolerance.
2. Cyclic manual stretching (Group B): Five to twenty seconds of stretching and 10 seconds of rest will be used 10 times in each of the following directions (flexion, scapular plane abduction, external rotation, and internal rotation) and stretch to target rotator cuff interval. The stretching dose will be determined based on the patient's level of irritability.
3. Group C: Fifteen patients will receive no physiotherapy treatment until the end of the study. As an ethical consideration, subjects in this group will receive the full treatment after the end of the study after data collection.
Statistical analysis:
Data will be analyzed using the statistical package for social sciences (SPSS) computer program version 24 software (IBM SPSS Inc., Chicago, IL, USA).
Descriptive statistics will be expressed as mean ± standard deviation for continuous variables.
The normality of data will be examined using Kolmogorov-Smirnov statistical test.
Repeated measures ANOVA test will be used to determine the difference between baseline and post-treatment scores for the ROM and time to gain ROM within each group.
Wilcoxon signed-rank test will be used to determine the difference between baseline and post-treatment scores for pain and function.
Kruskal Wallis ANOVA will be used for pain and function scores difference between groups (ordinal data).
A MANOVA test will be used to identify the difference between the three groups regarding ROM (flexion, extension, abduction, internal rotation, external rotation in adduction, and external rotation in abduction).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Static progressive stretch
Static progressive stretching
A stretching technique applies a mechanical progressive stretch
Cyclic manual stretch
Cyclic manual stretching
A stretching technique applies an intermittent manual stretch
No treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Static progressive stretching
A stretching technique applies a mechanical progressive stretch
Cyclic manual stretching
A stretching technique applies an intermittent manual stretch
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients aged between 40-65.
3. Pain duration of three months or more.
4. Range of motion loss of greater than 25% in at least 2 planes and passive external rotation loss that is greater than 50% of the uninvolved shoulder or less than 30° of external rotation.
Exclusion Criteria
2. Other conditions affecting the shoulder as (rheumatoid arthritis, osteoarthritis, rotator cuff disease, or malignancies).
3. Neurological deficits affecting shoulder function.
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaimaa Ramadan Ibrahim Abdul-ghani El Deab
assistant lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of physical therapy, Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004172
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.